济南男人的阴茎早泄怎么办济南早泄可以用中药治好吗,济南怎么才能不那么快射精,济南男性性功能下降时间,济南几分钟就射,济南无法勃起该怎样治疗,济南前列腺的一般症状,济南医院排名男科

SAN DIEGO (KGTV) - California gubernatorial candidate Gavin Newsom hosted a roundtable discussion at Grossmont College in El Cajon Wednesday, discussing the state’s ongoing housing crisis and other affordability issues Californians continue to face.On housing, Newsom said California's housing crisis revolves around affordability. He said the state is averaging 100,000 units statewide per year, but to reach an affordability equilibrium 400,000 a year is needed."We're 49th out of 50 in per capita housing units. Only Utah is producing less housing per capita. We can't double housing production and address the issue of affordability. We have an affordability crisis," Newsom said. "The next governor needs to be intense about this. Passionate about this.RELATED: Top candidates for California governor lay out plans to address affordable housing issue"We have no statewide housing goals in California. None. And that must change in January of next year."Newsom also touched on the controversial state gas tax.However, Newsom said while groups are quick to push back, they offer no alternative."There's no identifiable alternative dollars. So they're just going to erase -plus billion a year that's being invested as we speak in improving our infrastructure and addressing the deferred maintenance in the state," Newsom said. "It's easy politics to say no. But then they offer zero, nothing, in terms of an alternative."RELATED: San Diego's housing shortfall could grow if unchecked, report saysAn effort led by former San Diego Councilmember Carl DeMaio recently gathered enough signatures to place a repeal of the tax on the 2018 ballot. 1699

SAN DIEGO (KGTV) - Another child has been diagnosed with E. Coli linked to animals at the San Diego County Fair, San Diego Health and Human Services officials reported Tuesday. The latest case involves a 6-year-old boy who visited animals at the fair on June 22, officials said. The boy began showing symptoms of Shiga-toxin-producing E. Coli (STEC) four days later. He was not hospitalized. 2-year-old Jedediah Cabezuela died of the illness and three other children were sickened by E. Coli, fair organizers said Friday.RELATED: Family mourns toddler dead after E. Coli exposure at San Diego County FairHealth officials confirmed Tuesday a previously reported case involving a 9-year-old child who was not hospitalized was due to E. Coli. “As we continue our investigation, more cases are likely to be reported,” said Wilma J. Wooten, M.D., M.P.H, County public health officer. “This is typical of any public health investigation. Since we asked doctors to be on the lookout for STEC, they are more likely to test patients exhibiting symptoms.” E. Coli can incubate over a period of 10 days. Fair officials closed the animal exhibits to the public on June 28. RELATED: Two-year-old boy dead, three sickened due to E. Coli linked to San Diego County FairSymptoms of E. Coli include bloody or watery diarrhea, vomiting, and severe abdominal cramps. The infection is contracted through a naturally-occurring bacteria in animals. 1435

SAN DIEGO (KGTV) — As thousands of migrants part of a caravan from Honduras make their way north to the United States, the Department of Defense has updated how many troops may be sent to the border.Wednesday, the DOD reveal a list of potential stations where troops could be deployed along the U.S. southern border.This, as the group of migrants continue their journey north through Mexico, though still some time away from reaching their destination of Tijuana at press time.RELATED: 493

SAN DIEGO (KGTV) – Chick-fil-A participating locations will be hosting Military Appreciation Night Wednesday night.The popular chicken chain will be offering a free entrée and activities for all members of the military and their families.Activities at the Chula Vista restaurant on Olympic Parkway include a bounce house, crafts with Home Depot, a game truck, face-painting and a photo booth.The restaurant will be hosting several vendors offering raffle prizes including a barbeque grill, a big-screen TV, gift cards and 25 vouchers for a year’s worth of free Chick-fil-A.    604

SAN DIEGO (KGTV) -- As an active 45-year-old man who loves to surf and take adventures with his daughter, Bryce Olson was the last person his friends expected to get cancer.In 2014, a call while at work confirmed it: stage IV metastatic prostate cancer.Metastatic means the cancer has spread to other parts of the body, lymph nodes, bones or other organs.“It was just shocking and sad and I didn’t know anything about this stuff, so I just...I rolled into whatever my doctors were recommending," said Olson.He says the standard of care - surgery, chemotherapy, and the initial hormone therapy - wasn't working.“I started coming to terms with my own mortality. I didn’t even think I’d see my kid get out of elementary school and I was losing hope," said Olson.Olson says he wanted to make his final days count. The Intel employee started learning about precision medicine and eventually pursued DNA sequencing to find out exactly what was driving his disease.“I'm a believer in profiling your tumor at a molecular level and trying to understand what’s driving your unique disease, and then taking that data and then finding the right drug for the right person at the right time," said Olson.His results led him to a clinical trial in Los Angeles, where he was a perfect molecular match for the drug being tested.Four years later, Olson's precision medicine journey led him to San Diego's Epic Sciences.“We're actually going to a place where no test has gone before," said Murali Prahalad, President and CEO of Epic Sciences. "These are metastatic patients; the disease has already spread. And we’re trying to understand in the later stages of the disease when it’s far more complicated, how do you then understand which treatment is the right one.”Patients like Olson have two treatment options, chemotherapy or hormone therapy."It's very important to know which medicine is going to work," said Pascal Bamford, Chief Scientific Officer of Epic Sciences, "At the metastatic end of this disease every week, every day, every month is critically important."The company has created a blood test to make the choice easier, called the Oncotype DX AR-V7 Nucleus Detect.If the antigen AR-V7 is detected in a patient, they have built a resistance to hormone therapy, meaning chemotherapy would likely be a better treatment option.“We think it’s very groundbreaking, to say this is the first test that can tell a patient which drug to go on to extend their life," said Ryan Dittamore, Chief of Medical Innovation.Dittamore says the test helps provides certainty for doctors. Patients they've studied have almost doubled their life expectancy with the AR-V7 test.“It can mean the world, not only to patients but loved ones," said Dittamore.Olson was AR-V7 negative, meaning he could continue hormone therapy.Four months in, it's working. “I’m going to see my kid not only get out of high school but college and get married. I’m fully confident that I can do that because I’m just going to keep pushing," said Olson.In December 2018 the AR-V7 test will be covered by Medicare, meaning thousands of more men will have access to it. 3150